Feed Antibiotics Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Feed Antibiotics Market Trends and Insights

Rising Poultry and Swine Production Increases Medicated Feed Demand

Disease dynamics in dense production environments necessitate targeted therapeutic use under veterinary supervision, guided by surveillance data and prescribed durations of use ^{[1]Source: United States Food and Drug Administration, “Fact Sheet, Veterinary Feed Directive Final Rule and Next Steps,” U.S. Food and Drug Administration, fda.gov}. Positivity rates for porcine reproductive and respiratory syndrome increased in 2025, indicating ongoing respiratory challenges that heighten the need for treatment during swine finishing and nursery phases ^{[2]Source: Swine Health Information Center, “October 2025 SHIC eNewsletter,” Swine Health Information Center, swinehealth.org} . In large broiler complexes and integrated pork operations, standardized protocols for diagnosis, dosing, and withdrawal periods are integral to production risk management. Producers are adapting by integrating biosecurity measures, vaccination, and time-limited therapies, monitored through mill-veterinarian systems and audited process controls.

Compound Feed Growth Supports Antibiotic Volumes

The growth of compound feed production in key livestock economies continues to support the use of feed-based antibiotic delivery for approved therapeutic purposes. According to the Alltech Global Feed Survey, global compound feed production exceeded 1.39 billion metric tons in 2024, indicating consistent growth in livestock production systems. In China, compound feed production surpassed 315 million metric tons in 2024, as reported by the China Feed Industry Association. This growth has been driven by government efforts to modernize feed mills and enhance quality control measures, ensuring accurate dosing and improved traceability in medicated feed.

Cost-Effective Tetracyclines Remain Widely Used

Sales and usage data from 2025 identify tetracyclines as the largest class of medically important antimicrobials for food-producing animals in the United States, highlighting their broad-spectrum efficacy and value, which continue to influence purchasing decisions and treatment protocols. Global analyses emphasize their wide availability, pharmacokinetic familiarity, and established withdrawal schedules, maintaining tetracyclines as a preferred first-line option in various therapeutic contexts. Policy updates in Asia have restricted non-therapeutic applications while preserving access for veterinary prescriptions, ensuring therapeutic use in cases where animal health and welfare are at risk.

Veterinary Oversight Improves Compliance

The increasing role of veterinary oversight in livestock production systems is improving compliance with antibiotic usage protocols, ensuring controlled and traceable in-feed applications. As per the United States Food and Drug Administration, medically important antibiotics for food-producing animals in the United States are administered under veterinary authorization in accordance with Veterinary Feed Directive (VFD) regulations. This demonstrates the effective implementation of antibiotic stewardship policies. According to the United States Food and Drug Administration, antimicrobial sales for livestock in the United States declined by approximately 2% between 2022 and 2023, indicating enhanced compliance and a reduction in non-therapeutic usage.

Phase-Out of Growth Promoters Limits Usage

Regulatory authorities in key markets have implemented measures to prohibit the non-therapeutic use of antibiotics for growth promotion, while allowing their use for treatment, control, and prevention under specific conditions. In China, the Ministry of Agriculture and Rural Affairs has established policies banning antibiotic growth promoters and mandating veterinary oversight for therapeutic applications. Similarly, in North America, prescription requirements and Veterinary Feed Directive regulations have reclassified antibiotics as a supervised resource rather than a routine input, with clear guidelines on their duration and indications.

Demand for Antibiotic-Free Products Shifts Preferences

The growing demand for antibiotic-free meat and eggs is significantly influencing purchasing patterns, with a shift toward alternative feed solutions driven by regulatory actions and changing consumer preferences. This reflects the ongoing transition to antibiotic-free production systems, as producers seek to meet consumer expectations for healthier and more sustainable products. Additionally, the European Commission reports that European countries have adopted stringent antimicrobial resistance (AMR) reduction targets, further promoting the reduction of routine antibiotic use and encouraging the adoption of innovative feed strategies to maintain livestock health.

Segment Analysis

By Type: Tetracyclines Lead on Cost-Efficiency, While Macrolides Capture Therapeutic Value

Tetracyclines accounted for the largest 65.0% of the global feed antibiotics market share in 2025, while the global feed antibiotics market size for macrolides is projected to achieve the fastest segment growth with a 3.8% CAGR from 2026 to 2031, highlighting their distinct roles in managing respiratory and enteric disease complexes. In the United States, tetracyclines held the largest share of medically important antimicrobial sales for food-producing animals in 2024, emphasizing their role in cost-effective therapy with established withdrawal schedules. Pleuromutilins continue to gain traction in swine, driven by established products and ongoing label expansions that enhance their clinical utility for mycoplasma and respiratory pathogens ^{[3]Source: ECO Animal Health Group plc, “Annual Report 2024,” ECO Animal Health Group plc, ecoanimalhealth.com}. 

Ionophores, which are not classified as medically important for human medicine, remain widely utilized in poultry coccidiosis programs and support feed-conversion control strategies under specific regulatory frameworks. Within the broader therapeutic landscape, aminoglycosides, sulfonamides, and penicillins address specific indications based on pathogen profiles and farm-stage requirements, with veterinarians tailoring treatments to disease pressures and documented susceptibilities. Looking ahead, the feed antibiotics market is projected to see increased use of macrolides in targeted applications, where label convenience and defined durations align with oversight and labor constraints. 

By Animal Type: Poultry Market Growth Driven by Broiler Density and Metaphylaxis Practices

Poultry held the largest 38.0% of the global feed antibiotics market share in 2025, and the global feed antibiotics animal market size for poultry is projected to grow fastest at a 4.0% CAGR from 2026 to 2031, driven by disease-management needs in high-capacity broiler systems and the interplay of vaccines and targeted therapeutics. Integrators deploy vaccination and ionophore programs at scale and maintain access to in-feed antibiotics for indicated conditions under veterinary oversight, which balances label-claim aspirations with animal health imperatives. In swine, persistent respiratory disease pressure has kept therapeutic options important, with positivity rates for key viral pathogens reinforcing the need for clearly defined metaphylaxis plans managed by mill and veterinarian teams. 

Within the feed antibiotics market, veterinarians tailor class selection and dosing based on species, production stage, and pathogen profile, which leads to distinct usage patterns across poultry, swine, ruminants, and aquaculture. Retail and export programs that stipulate negative-antibiotic claims have increased traceability obligations for integrators, which in turn shape how mill-veterinarian teams schedule and document therapeutic courses. This environment favors clear labels, sustained-release options, and validated withdrawal periods that can withstand audit in channels with elevated verification expectations.

Geography Analysis

Asia-Pacific accounted for the largest 35.0% of the feed antibiotics market share in 2025, and the feed antibiotics market size for Asia-Pacific is projected to grow at the fastest CAGR of 4.2% from 2026 to 2031. This growth reflects the region's significant poultry and swine production, ongoing modernization of feed mills, and veterinary oversight for therapeutic applications. According to the United States Department of Agriculture, poultry production is projected to reach approximately 15.8 million metric tons in 2026, with growth driven by white-broiler production. White-broiler systems account for nearly 70% of total output, supported by vertically integrated operations that dominate industrial poultry production.

North America is driven by formal oversight frameworks and disease management needs, particularly in cattle and swine. The 2026 duration-of-use initiative enhances label clarity for selected in-feed approvals, reducing historical ambiguity around continuous use and aiding planning for feedlots and large integrators. In 2024, United States sales data indicated a significant share held by tetracyclines among medically important antibiotics, reflecting their widespread utility and cost-effectiveness for respiratory and enteric conditions. Swine health surveillance in 2025 recorded elevated numbers of cases of porcine reproductive and respiratory syndrome, underscoring the ongoing demand for supervised therapy at finishing and nursery sites. 

Europe is shaped by the region's long-standing prohibition on antibiotic growth promoters and its emphasis on veterinary oversight for therapeutic use. National regulators collaborate with international standards bodies to enhance medicine governance, promoting improved stewardship and residue control in feed-based therapies. Producers in Europe continue to invest in vaccination, enzymes, and phytogenics while maintaining access to in-feed antibiotics for labeled indications under veterinary supervision. As supply chains expand antibiotic-free offerings, processors and retailers demand more rigorous compliance evidence, increasing documentation requirements for feed mills and farms.